SCHEMBL13394243

SCHEMBL13394243

Cc1cn2[nH]c3ccccc3c2n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 1/20 0.42
ALOX5 P09917 1/20 0.42
HAVCR2 Q8TDQ0 2/20 0.40
KDM4E B2RXH2 3/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 2/20 0.38
NPC1 O15118 1/20 0.38
PKM P14618 1/20 0.38
MAPK1 P28482 1/20 0.38
RAB9A P51151 1/20 0.38
ATM Q13315 1/20 0.37
TSHR P16473 1/20 0.36
TP53 P04637 2/20 0.35
RXFP1 Q9HBX9 2/20 0.35
PDE10A Q9Y233 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6287822 0.67 MAT2A (0.43) HSD17B10ALDH1A1HPGDKDM4ELMNA
SCHEMBL30890464 0.67 ALOX5 (0.40) HSD17B10ALDH1A1ALOX5PDE10A
SCHEMBL30947870 0.65 NQO2 (0.51) HSD17B10ALDH1A1HPGDHAVCR2KDM4E
SCHEMBL6282267 0.64 ALDH1A1 (0.35) HSD17B10ALDH1A1HPGDLMNASMN1; SMN2
SCHEMBL6288499 0.64 ALDH1A1 (0.35) HSD17B10ALDH1A1HPGD
SCHEMBL3256643 0.62 ALDH1A1 (0.54) HSD17B10ALDH1A1HPGDKDM4ELMNA
SCHEMBL861330 0.62 HSD17B10 (0.47) HSD17B10ALDH1A1HPGDKDM4ELMNA
SCHEMBL30336436 0.59 ALOX5 (1.00) ALOX5KDM4ETP53
SCHEMBL30389590 0.59 ALOX5 (0.44) HSD17B10ALDH1A1ALOX5RXFP1
SCHEMBL2673327 0.59 ALOX5 (1.00) ALOX5KDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420052-B2 Imaging agents useful for identifying AD pathology SIEMENS MEDICAL SOLUTIONS USA, INC. (US) 2013-04-16 US disclosed
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology SIEMENS MEDICAL SOLUTIONS USA, INC. 2010-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100098634-A1 Imaging Agents Useful for Identifying AD Pathology APP, APBA1, PYGB HSD17B10 3219/4885ALDH1A1 1389/4885HPGD 2793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.